These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 31919699)
1. Clinical potential and current progress of mesenchymal stem cells for Parkinson's disease: a systematic review. Chen Y; Shen J; Ke K; Gu X Neurol Sci; 2020 May; 41(5):1051-1061. PubMed ID: 31919699 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease? Vilaça-Faria H; Salgado AJ; Teixeira FG Cells; 2019 Feb; 8(2):. PubMed ID: 30717429 [TBL] [Abstract][Full Text] [Related]
3. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease. Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ Cells; 2020 Jan; 9(2):. PubMed ID: 32012897 [TBL] [Abstract][Full Text] [Related]
4. The prospective role of mesenchymal stem cells in Parkinson's disease. Tambe P; Undale V; Sanap A; Bhonde R; Mante N Parkinsonism Relat Disord; 2024 Oct; 127():107087. PubMed ID: 39142905 [TBL] [Abstract][Full Text] [Related]
5. TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson's disease models and patients. Zhuo Y; Li WS; Lu W; Li X; Ge LT; Huang Y; Gao QT; Deng YJ; Jiang XC; Lan ZW; Deng Q; Chen YH; Xiao Y; Lu S; Jiang F; Liu Z; Hu L; Liu Y; Ding Y; He ZW; Tan DA; Duan D; Lu M Mil Med Res; 2024 Jul; 11(1):48. PubMed ID: 39034405 [TBL] [Abstract][Full Text] [Related]
6. The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment. Heris RM; Shirvaliloo M; Abbaspour-Aghdam S; Hazrati A; Shariati A; Youshanlouei HR; Niaragh FJ; Valizadeh H; Ahmadi M Stem Cell Res Ther; 2022 Jul; 13(1):371. PubMed ID: 35902981 [TBL] [Abstract][Full Text] [Related]
7. Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells. Bagheri-Mohammadi S; Karimian M; Alani B; Verdi J; Tehrani RM; Noureddini M J Cell Physiol; 2019 Feb; 234(2):1326-1335. PubMed ID: 30146713 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease. Venkatesh K; Sen D Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480 [TBL] [Abstract][Full Text] [Related]
9. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against Parkinson's disease. Abrishamdar M; Jalali MS; Yazdanfar N Neurol Sci; 2023 Jul; 44(7):2277-2289. PubMed ID: 36949298 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells and neuroregeneration in Parkinson's disease. Glavaski-Joksimovic A; Bohn MC Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820 [TBL] [Abstract][Full Text] [Related]
11. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease. Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785 [TBL] [Abstract][Full Text] [Related]
12. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease. d'Angelo M; Cimini A; Castelli V Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092 [TBL] [Abstract][Full Text] [Related]
13. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects. Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases. Staff NP; Jones DT; Singer W Mayo Clin Proc; 2019 May; 94(5):892-905. PubMed ID: 31054608 [TBL] [Abstract][Full Text] [Related]
15. Old and new challenges in Parkinson's disease therapeutics. Pires AO; Teixeira FG; Mendes-Pinheiro B; Serra SC; Sousa N; Salgado AJ Prog Neurobiol; 2017 Sep; 156():69-89. PubMed ID: 28457671 [TBL] [Abstract][Full Text] [Related]
16. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. Lo Furno D; Mannino G; Giuffrida R J Cell Physiol; 2018 May; 233(5):3982-3999. PubMed ID: 28926091 [TBL] [Abstract][Full Text] [Related]
17. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine. Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958 [TBL] [Abstract][Full Text] [Related]
18. Harnessing Stem Cells and Neurotrophic Factors with Novel Technologies in the Treatment of Parkinson's Disease. Conese M; Cassano R; Gavini E; Trapani G; Rassu G; Sanna E; Di Gioia S; Trapani A Curr Stem Cell Res Ther; 2019; 14(7):549-569. PubMed ID: 30827260 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of Mesenchymal Stem Cells as a Multitarget Disease- Modifying Therapy for Parkinson's Disease. Unnisa A; Dua K; Kamal MA Curr Neuropharmacol; 2023; 21(4):988-1000. PubMed ID: 35339180 [TBL] [Abstract][Full Text] [Related]